Dongxing Medical announced plans to repurchase company shares using its own funds through centralized bidding. The buyback amount will be no less than 20 million yuan and no more than 40 million yuan, with a maximum price of 41.7 yuan per share. The estimated number of shares to be repurchased ranges from 480,000 to 960,000, accounting for 0.48% to 0.96% of the total share capital. In the first quarter of 2026, the company achieved revenue of 90.47 million yuan and net profit attributable to the parent company of 17.92 million yuan.
Jiangsu Canopus Wisdom Medical Technology Co. Ltd. ACompany announces share buyback of 20-40 million yuan, signaling confidence and supporting stock price.